Sabra Health Care REIT, Inc. (SBRA)

Over the past six months, Sabra's stock has been impacted by several events. The company reported strong financial performance in Q2 and Q3 2025, with increased Normalized FFO and AFFO per share. Revenue and occupancy also grew, particularly in the same-store managed senior housing portfolio. Sabra strategically acquired six managed senior housing properties and purchased the operations of four others. Moody's upgraded Sabra's senior unsecured notes rating to "Baa3" due to its sound operating performance and diversified portfolio. A quarterly cash dividend of $0.30 per share was declared. Sabra issued 9.6 million shares, generating net proceeds of $165.0 million, and entered into a new $750 million at-the-market (ATM) program. As of February 6, 2026, the closing stock price was $19.03, with a 52-week high of $19.97 and a low of $15.60.

While healthcare demand is generally consistent, there can be some seasonality in specific segments. Sabra's Q1 2025 report noted that its managed senior housing portfolio's revenue, cash net operating income (NOI), and margins were flat sequentially, which "defied expectations of seasonal dips." The aging U.S. population is a powerful tailwind, driving persistent demand for Sabra's core asset classes.

Sabra Health Care REIT, Inc. (SBRA), founded in 2010 and headquartered in Irvine, California, is a real estate investment trust (REIT) focused on acquiring, financing, and owning healthcare real estate properties. The company invests in senior housing properties (independent living, assisted living, and memory care facilities), skilled nursing facilities/transitional care facilities, medical office buildings, and behavioral health facilities & specialty hospitals. Sabra generates revenue through rent collection from tenants under long-term leases and operating income from managed senior housing communities.

Sabra Health Care REIT, Inc. has a geographic footprint that spans across the United States and Canada, with approximately 37,834 beds/units across these regions.

Sabra Health Care REIT, Inc.'s brand reputation has been positively influenced by its strong operational and financial performance. The upgrade of its senior unsecured notes rating to "Baa3" by Moody's is a significant indicator of a strong reputation. The company emphasizes its commitment to supporting high-quality care through its real estate investments.

Sabra Health Care REIT, Inc. is predominantly owned by institutional investors, holding nearly 98% of the shares. Major institutional shareholders include BlackRock, Inc., Vanguard Group Inc., and Principal Financial Group Inc. Insider ownership accounts for approximately 1.22% of the company.